Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients

Our study aimed to assess the applicability of miR-486 in combination with soluble GP88 protein as a diagnostic and/or predictive biomarker for prostate cancer (PCa) patients. miR-486 and GP88 levels in serum samples from 136 patients undergoing MRI-guided biopsy of the prostate were assessed by qRT...

詳細記述

書誌詳細

出版年:	Life
主要な著者:	Alexander Fichte, Angela Neumann, Katrin Weigelt, Juan Guzman, Thilo Jansen, Julia Keinert, Ginette Serrero, Binbin Yue, Robert Stöhr, Thomas Greither, Arndt Hartmann, Bernd Wullich, Helge Taubert, Sven Wach, Verena Lieb
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-05-01
主題:	progranulin miRNAs prostate cancer serum level predictive biomarker age
オンライン･アクセス:	https://www.mdpi.com/2075-1729/12/5/732